Left ventricular ejection time in acute heart failure complicating precapillary pulmonary hypertension

Chest

Volumn 144, Issue 5, 2013, Pages 1512-1520

  Sztrymf, Benjamin ^a,b,c,d   Günther, Sven ^c,d   Artaud Macari, Elise ^c,d   Savale, Laurent ^c,d   Jaïs, Xavier ^c,d   Sitbon, Olivier ^c,d   Simonneau, Gérald ^c,d   Humbert, Marc ^b,c,d   Chemla, Denis ^b,c  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; CREATININE; DOBUTAMINE; FUROSEMIDE; ILOPROST; NORADRENALIN; OXYGEN; PROSTACYCLIN; SILDENAFIL; TADALAFIL; TREPROSTINIL;

ACUTE HEART FAILURE; ADULT; AGED; AORTA PRESSURE; ARTICLE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FORWARD HEART FAILURE; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; TONOMETRY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84887438135     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2659     Document Type: Article

References (33)

1. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol. 2008;51(16):1527-1538.
2. Sztrymf B, Humbert M. Practical management of pulmonary arterial hypertension in the intensive care unit. In: Humbert M, Lynch JP III, eds. Pulmonary Hypertension. New York, NY: Informa Heathcare USA; 2009:455-461.
3. Kurzyna M, Zylkowska J, Fijalkowska A, et al. Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. Kardiol Pol. 2008;66(10):1033-1039.
4. Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35(6):1286-1293.
5. Campo A, Mathai SC, Le Pavec J, et al. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J. 2011;38(2):359-367.
6. Haddad F, Peterson T, Fuh E, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail. 2011;4(6):692-699.
7. Van De Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011;58(24):2511-2519.
8. Marcus JT, Gan CT, Zwanenburg JJ, et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol. 2008;51(7):750-757.
9. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932-937.
10. Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95(7):1827-1836.
11. Chemla D, Plamann K, Nitenberg A. Towards new indices of arterial stiffness using systolic pulse contour analysis: a theoretical point of view. J Cardiovasc Pharmacol. 2008;51(2):111-117.
12. Pini R, Cavallini MC, Palmieri V, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol. 2008;51(25):2432-2439.
13. O'Rourke MF, Adji A. Noninvasive studies of central aortic pressure. Curr Hypertens Rep. 2012;14(1):8-20.
14. Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184(10):1114-1124.
15. McLaughlin VV, Archer SL, Badesch DB, et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-2294.
16. Rattes M, Calvin JE. Acute pulmonary hypertension. In: Pinsky MR, Dhainaut JF, eds. Pathophysiologic Foundations of Critical Care. Baltimore, MD: Williams and Wilkins; 1993:312-336.
17. O'Rourke MF, Adji A. An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol. 2005;20(4):275-281.
18. Agabiti-Rosei E, Mancia G, O'Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50(1):154-160.
19. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48(12):2546-2552.
20. Cleland JG, Teerlink JR, Senior R, et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebocontrolled, crossover, dose-ranging phase 2 trial. Lancet. 2011;378(9792):676-683.
21. Teerlink JR, Clarke CP, Saikali KG, et al. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet. 2011;378(9792):667-675.
22. Weissler AM. Estimation of the risk of death after acute myocardial infarction from systolic time intervals. Br Heart J 1990;64(3):227.
23. Boudoulas H. Systolic time intervals. Eur Heart J. 1990;11(suppl I):93-104.
24. Singer M, Allen MJ, Webb AR, Bennett ED. Effects of alterations in left ventricular filling, contractility, and systemic vascular resistance on the ascending aortic blood velocity waveform of normal subjects. Crit Care Med. 1991;19(9):1138-1145.
25. Roeleveld RJ, Marcus JT, Faes TJ, et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology. 2005;234(3):710-717.
26. Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-tofree wall curvature ratio measured at cardiac MR. Radiology 2007;243(1):63-69.
27. Lopez-Candales A, Edelman K, Gulyasy B, Candales MD. Differences in the duration of total ejection between right and left ventricles in chronic pulmonary hypertension. Echocardiography. 2011;28(5):509-515.
28. Dong SJ, Smith ER, Tyberg JV. Changes in the radius of curvature of the ventricular septum at end diastole during pulmonary arterial and aortic constrictions in the dog. Circulation. 1992;86(4):1280-1290.
29. Kapitan KS, Buchbinder M, Wagner PD, Moser KM. Mecha nisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis. 1989;139(5):1149-1154.
30. Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest. 1979;64(4):1050-1055.
31. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41(6):1028-1035.
32. Vodoz JF, Cottin V, Glérant JC, et al. Right-to-left shunt with hypoxemia in pulmonary hypertension. BMC Cardiovasc Disord. 2009;9:15.
33. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respire Crit Care Med. 2006;173(9):1023-1030.